Results 111 to 120 of about 7,988 (196)

Taming Bacterial Toxins into an Anticancer Platform. [PDF]

Biochem Biophys Res Commun
Yang C, Chen C.
europepmc   +1 more source

Editorial: Combination therapies in cancer treatment: enhancing efficacy and reducing resistance. [PDF]

Front Pharmacol
Wang X, Pešić M, Podolski-Renić A.
europepmc   +1 more source

Contempo 90: Transplantation [PDF]

, 1990
Fung, JJ, Starzl, TE
core  

Immunotoxin [PDF]

, 2020
openaire   +1 more source

Bacterial Protein Toxins as Anticancer Agents: Clinical Potential of <i>Pseudomonas</i> and Anthrax Toxins. [PDF]

Toxins (Basel)
Misra R, Gupta R, Nayyar N, Baweja R, Sharma V, Singh Y, Baweja R.   +6 more
europepmc   +1 more source

An Innovative Immunotoxin Design Against Allergy Based on the IL-33 Cytokine and the Ribotoxin α-Sarcin. [PDF]

Int J Mol Sci
Narbona J, Lázaro-Gorines R, Gutiérrez-Carmona A, López-Rodríguez JC, Villalba M, Lacadena J.   +5 more
europepmc   +1 more source

Dual targeting NG2 and GD3A using Mab-Zap immunotoxin results in reduced glioma cell viability in vitro [PDF]

, 2015
Ashkan, Keyoumars, Butt, Arthur M., Fillmore, Helen L., Higgins, Samantha C., Pilkington, Geoffrey J.   +4 more
core   +1 more source

Unlocking the potential of engineered microbes in immunotoxin-based cancer therapy. [PDF]

Front Microbiol
Wang Q, Cao R, Xie Y, Zhang Z, Li X, Zhang Y, Luo H, Yao H, Xue P, Ni S.   +9 more
europepmc   +1 more source

The use of chimeric bacterial and plant protein toxins for targeted chemotherapy [PDF]

, 1905
Alouf, J.E.
core   +1 more source

Design and Characterization of Ricin Based Immunotoxins Against EPHA2 Receptor for Breast Cancer Therapy: An In-Silico Study. [PDF]

Iran J Pharm Res
Faraz A, Amani J, Arbabian S, Zare Karizi S, Bikhof Torbati M.   +4 more
europepmc   +1 more source